Spots Global Cancer Trial Database for trop2
Every month we try and update this database with for trop2 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01) | NCT05104866 | Breast Cancer | Dato-DXd Capecitabine Gemcitabine Eribulin Vinorelbine | 18 Years - | AstraZeneca | |
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors | NCT05941507 | Advanced Solid ... | LCB84 Anti-PD-1 monoc... | 18 Years - | LigaChem Biosciences, Inc. | |
A Study of Dato-DXd With or Without Durvalumab Versus Investigator's Choice of Therapy in Patients With Stage I-III Triple-negative Breast Cancer Without Pathological Complete Response Following Neoadjuvant Therapy (TROPION-Breast03) | NCT05629585 | Breast Cancer | Dato-DXd Durvalumab Capecitabine Pembrolizumab | 18 Years - 130 Years | AstraZeneca | |
A Phase 1/2 Study of PBI-410 in Advanced Solid Tumors | NCT06384807 | Solid Tumor | PBI-410 | 18 Years - | Pyramid Biosciences |